Buthainah Ghanem

3PUBLICATIONS

0CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 12, 2023

Efficacy, safety, and cost-minimization analysis of axicabtagene ciloleucel and tisagenlecleucel CAR T-Cell therapies for treatment of relapsed or refractory follicular lymphoma.

Buthainah Ghanem

|Nov 01, 2022

Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US.

Buthainah Ghanem, Lu Shi

|Sep 28, 2022

The Economic Burden of CAR T Cell Therapies Ciltacabtagene Autoleucel and Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US.

Buthainah Ghanem, Lu Shi

Pageof 1

Frequent Collaborators

Frequent Collaborators